Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity

v3.21.2
Condensed Consolidated Statement of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Series A Perpetual Preferred Stock [Member]
Common Stock [Member]
Shares Issuable [Member]
Treasury Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Non-Controlling Interests [Member]
Total
Balance at Dec. 31, 2019 $ 1 $ 74 $ 500   $ 461,874 $ (436,234) $ 46,317 $ 72,532
Balance (in shares) at Dec. 31, 2019 1,341,167 74,027,425            
Stock-based compensation expense         7,148     7,148
Issuance of common stock related to equity plans   $ 2     (2)      
Issuance of common stock related to equity plans (in shares)   2,038,431            
Issuance of common stock under ESPP         90     90
Issuance of common stock under ESPP (in shares)   53,268            
Preferred A dividends declared and paid         (2,788)     (2,788)
Partner company's at-the-market offering, net         10,447     10,447
Issuance of common stock for at-the-market offering, net   $ 10     22,073     22,083
Issuance of common stock for at-the-market offering, net (in shares)   9,314,020            
Repurchase of Series A preferred stock, net       $ (70) (2)     (72)
Repurchase of Series A preferred stock (in shares) (5,000)              
Retirement of Series A preferred stock       70 (70)      
Issuance of Series A preferred stock for cash, net $ 2       23,501     23,503
Issuance of Series A preferred stock for cash, net (in shares) 1,357,639.0              
Partner company's offering, net         34,924     34,924
Partner company's exercise of warrants for cash         13     13
Partner company's ESPP         169     169
Issuance of partner company's common shares for research and development expenses         21     21
Common shares issued for 2017 Subordinated Note Financing interest expense     (500)   1,006     506
Common shares issued for 2017 Subordinated Note Financing interest expense (in shares)   680,187            
Common shares issuable for 2017 Subordinated Note Financing interest expense     500         500
Common shares issuable for 2019 Notes interest expense     313         313
Non-controlling interest in subsidiaries/partner companies         (36,911)   36,911  
Net loss attributable to non-controlling interest             (26,847) (26,847)
Net loss attributable to common stockholders           (25,684)   (25,684)
Balance at Jun. 30, 2020 $ 3 $ 86 813   521,493 (461,918) 56,381 116,858
Balance (in shares) at Jun. 30, 2020 2,693,806 86,113,331            
Balance at Mar. 31, 2020 $ 2 $ 79 661 (70) 485,160 (448,604) 38,057 75,285
Balance (in shares) at Mar. 31, 2020 2,054,917 78,572,169            
Stock-based compensation expense         3,748     3,748
Issuance of common stock related to equity plans (in shares)   86,024            
Issuance of common stock under ESPP         90     90
Issuance of common stock under ESPP (in shares)   53,268            
Preferred A dividends declared and paid         (1,581)     (1,581)
Partner company's at-the-market offering, net         5,537     5,537
Issuance of common stock for at-the-market offering, net   $ 7     16,196     16,203
Issuance of common stock for at-the-market offering, net (in shares)   6,973,020            
Retirement of Series A preferred stock       $ 70 (70)      
Issuance of Series A preferred stock for cash, net $ 1       10,435     10,436
Issuance of Series A preferred stock for cash, net (in shares) 638,889              
Partner company's offering, net         34,924     34,924
Issuance of partner company's common shares for research and development expenses         21     21
Common shares issued for 2017 Subordinated Note Financing interest expense     (506)   506      
Common shares issued for 2017 Subordinated Note Financing interest expense (in shares)   428,850            
Common shares issuable for 2017 Subordinated Note Financing interest expense     500         500
Common shares issuable for 2019 Notes interest expense     158         158
Non-controlling interest in subsidiaries/partner companies         (33,473)   33,473  
Net loss attributable to non-controlling interest             (15,149) (15,149)
Net loss attributable to common stockholders           (13,314)   (13,314)
Balance at Jun. 30, 2020 $ 3 $ 86 813   521,493 (461,918) 56,381 116,858
Balance (in shares) at Jun. 30, 2020 2,693,806 86,113,331            
Balance at Dec. 31, 2020 $ 3 $ 95     583,000 (482,760) 96,661 196,999
Balance (in shares) at Dec. 31, 2020 3,427,138 94,877,492            
Stock-based compensation expense         8,123     8,123
Issuance of common stock related to equity plans   $ 2     (2)      
Issuance of common stock related to equity plans (in shares)   2,558,645            
Issuance of common stock under ESPP         137     137
Issuance of common stock under ESPP (in shares)   59,107            
Preferred A dividends declared and paid         (4,015)     (4,015)
Partner company's at-the-market offering, net         97,332     97,332
Partner company's exercise of options for cash         7     7
Issuance of common stock under partner company's ESPP         158     158
Partner company's dividends declared and paid         (375)     (375)
Issuance of partner company's common shares for research and development expenses         129     129
Common shares issuable for dividend on partner company's convertible preferred shares     263         263
Non-controlling interest in subsidiaries/partner companies         (81,459)   81,459  
Net loss attributable to non-controlling interest             (38,100) (38,100)
Net loss attributable to common stockholders           (12,357)   (12,357)
Balance at Jun. 30, 2021 $ 3 $ 97 263   603,035 (495,117) 140,020 248,301
Balance (in shares) at Jun. 30, 2021 3,427,138 97,495,244            
Balance at Mar. 31, 2021 $ 3 $ 97     597,384 (491,582) 138,323 244,225
Balance (in shares) at Mar. 31, 2021 3,427,138 97,263,054            
Stock-based compensation expense         4,350     4,350
Issuance of common stock related to equity plans (in shares)   173,083            
Issuance of common stock under ESPP         137     137
Issuance of common stock under ESPP (in shares)   59,107            
Preferred A dividends declared and paid         (2,008)     (2,008)
Partner company's at-the-market offering, net         25,910     25,910
Partner company's dividends declared and paid         (188)     (188)
Issuance of partner companies' common shares for research and development expenses         3     3
Common shares issuable for dividend on partner company's convertible preferred shares     263         263
Non-controlling interest in subsidiaries/partner companies         (22,553)   22,553  
Net loss attributable to non-controlling interest             (20,856) (20,856)
Net loss attributable to common stockholders           (3,535)   (3,535)
Balance at Jun. 30, 2021 $ 3 $ 97 $ 263   $ 603,035 $ (495,117) $ 140,020 $ 248,301
Balance (in shares) at Jun. 30, 2021 3,427,138 97,495,244